Slingshot Insights | Clsd Overview

CLSD Overview

Upcoming Projects (CLSD)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (CLSD)

Delving into the topline results from the phase 2b ODYSSEY clinical trial of suprachoroidal CLS-AX in wet AMD.
Tickers: CLSD, OCUL
Executed On: Oct 30, 2024 at 06:00 PM EDT

Expired Projects (CLSD)

Examining Uveitic Macular edema space ahead of the PDUFA date for XIPERE -October 19, 2019
Ticker: CLSD
Execute By: Oct 31, 2019

Upcoming & Overdue Catalysts (CLSD)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (CLSD)

Clearside Biomedical's (CLSD) Phase 3 SAPPHIRE trial of Suprachoroidal CLS-TA in Macular edema associated with retinal vein occlusion (RVO) Preliminary data due 4Q 2018
Ticker: CLSD
Occurred on: Nov 05, 2018
Clearside Biomedical's (CLSD) Phase 2 preliminary data of Suprachoroidal CLS-TA - TYBEE in Diabetic Macular Edema (DME) expected in 2Q 2018
Ticker: CLSD
Occurred on: May 31, 2018
Phase 1/2 Preliminary data from Clearside Biomedical's (CLSD) Suprachoroidal CLS-TA - HULK Trial in Diabetic macular edema (DME) due 2Q 2018
Ticker: CLSD
Occurred on: Dec 13, 2017

Strategic Initiatives (CLSD)

Don’t see a strategic initiative related to the company you care about? Create your own!